MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MCU | Mitochondrial calcium uniporter | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
NCOA5 | Nuclear receptor coactivator 5 | Predicted intracellular proteins
| | | | | Expressed in all |
NDUFAF2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
NKX6-1 | NK6 homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PARP1 | Poly (ADP-ribose) polymerase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PASK | PAS domain containing serine/threonine kinase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PC | Pyruvate carboxylase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
PDK2 | Pyruvate dehydrogenase kinase, isozyme 2 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
PER2 | Period circadian clock 2 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PKN1 | Protein kinase N1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PPARG | Peroxisome proliferator-activated receptor gamma | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PPP3CA | Protein phosphatase 3, catalytic subunit, alpha isozyme | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRKAB1 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit | FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PRKAG2 | Protein kinase, AMP-activated, gamma 2 non-catalytic subunit | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRKAR2A | Protein kinase, cAMP-dependent, regulatory, type II, alpha | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PRKCI | Protein kinase C, iota | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RAB11B | RAB11B, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
RAB11FIP2 | RAB11 family interacting protein 2 (class I) | Predicted intracellular proteins
| | | | | Expressed in all |
RAB11FIP5 | RAB11 family interacting protein 5 (class I) | Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
RAB8A | RAB8A, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
REPIN1 | Replication initiator 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
RPS6 | Ribosomal protein S6 | Predicted intracellular proteins Ribosomal proteins
| | | | | Expressed in all |
S100A6 | S100 calcium binding protein A6 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SH2B2 | SH2B adaptor protein 2 | Predicted intracellular proteins
| | | | | Mixed |
SIRT1 | Sirtuin 1 | Predicted intracellular proteins
| | | | | Expressed in all |
SLC16A1 | Solute carrier family 16 (monocarboxylate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC27A4 | Solute carrier family 27 (fatty acid transporter), member 4 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SMAD2 | SMAD family member 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
SNX1 | Sorting nexin 1 | Predicted intracellular proteins
| | | | | Expressed in all |
SNX6 | Sorting nexin 6 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SORT1 | Sortilin 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
SOX4 | SRY (sex determining region Y)-box 4 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
SRI | Sorcin | Predicted intracellular proteins
| | | | | Expressed in all |
SSTR5 | Somatostatin receptor 5 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
STAT1 | Signal transducer and activator of transcription 1, 91kDa | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
STK11 | Serine/threonine kinase 11 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |